Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn’s Disease Patients
出版年份 2023 全文链接
标题
Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn’s Disease Patients
作者
关键词
-
出版物
EUROPEAN SURGICAL RESEARCH
Volume -, Issue -, Pages 1-10
出版商
S. Karger AG
发表日期
2023-10-12
DOI
10.1159/000533594
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn’s Disease in the Era of Biologic Therapy
- (2022) Mohamed A Abd El Aziz et al. Journal of Crohns & Colitis
- Hypoalbuminemia, Not Biologic Exposure, is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection
- (2021) Ravi S Shah et al. Journal of Crohns & Colitis
- Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
- (2021) Anthony Buisson et al. United European Gastroenterology Journal
- The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
- (2021) Daniele Noviello et al. Frontiers in Immunology
- Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis
- (2021) Daxin Guo et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
- (2021) María José García et al. Journal of Clinical Medicine
- Major Surgical Trauma Impairs the Function of Natural Killer Cells but Does Not Affect Monocyte Cytokine Synthesis
- (2021) Roman M. Müller-Heck et al. Life-Basel
- Vedolizumab Induced Clinical, Endoscopic, and Histological Improvement in Common Variable Immunodeficiency Disease–associated Intestinal Enteropathy
- (2020) Hisham Javed Akhtar et al. INFLAMMATORY BOWEL DISEASES
- A comprehensive review and update on Crohn's disease
- (2018) Mahesh Gajendran et al. DM DISEASE-A-MONTH
- Anti-interleukin-12 and anti-interleukin-23 agents in Crohn’s disease
- (2018) Fabio Salvatore Macaluso et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis
- (2018) Matteo Novello et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease
- (2017) Amy L Lightner et al. Journal of Crohns & Colitis
- Inflammatory and Immune Responses to Surgery and Their Clinical Impact
- (2016) William Alazawi et al. ANNALS OF SURGERY
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970–2004)
- (2012) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- Surgery for Crohn’s disease in the era of biologicals: A reduced need or delayed verdict?
- (2012) Anthony de Buck van Overstraeten WORLD JOURNAL OF GASTROENTEROLOGY
- Minimally invasive colectomy for Crohnʼs colitis: A single institution experience
- (2010) Stefan D. Holubar et al. INFLAMMATORY BOWEL DISEASES
- Neuroimmune mechanisms in postoperative ileus
- (2009) G E Boeckxstaens et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More